When first-line treatment is no longer controlling the disease.
For some clients with advanced cancer, the initial treatment may not achieve the expected response. Further evaluation helps the care team consider appropriate next steps together.
Precision oncology by Sameta Biomedical
DNA-Driven Analytics
for Precision Oncology.
OmixMe's personalized medical analysis identifies your unique genetic profile, helping doctors explore targeted therapies that may improve cancer survival rates and reduce side effects.
Every tumour has its own molecular characteristics, which can influence how it responds to treatment.
Four considerations where molecular biology may offer additional insight alongside standard approaches in cancer care.
It can be difficult to understand why.
Two clients with the same diagnosis may follow the same protocol, yet respond differently for distinct molecular reasons. Without deeper molecular insight, some uncertainty can remain in each decision.
Treatment timelines can be a significant consideration.
Finding the most suitable approach may take time, with each protocol needing careful evaluation. Molecular insight can sometimes help inform decisions earlier in the process.
Many clinical trials require molecular data.
A large share of trials use molecular criteria that hospitals don't routinely generate. With that data in hand, your eligibility for specific trials can be assessed more precisely.
Precision Oncology: 3 Layers of AI-Driven Evidence for Targeted Cancer Treatment.
We integrate deep DNA sequencing, liquid biopsy blood monitoring, and AI-driven clinical trial matching to provide your oncologist with a molecular GPS for highly targeted cancer care.
Multi-omics tumour profiling
We sequence cancer-relevant genes and analyse RNA expression so your doctor can see molecular signals that standard biopsies don't reveal.
Whole Genome Analysis
Sequencing and analysing an individual's entire DNA to identify genetic mutations, structural changes, and other genomic alterations associated with disease, including cancer.
AI-driven bioinformatics
Your molecular profile is matched against the global evidence base to help predict which therapies are most likely to work on your specific tumour — not on an average client.
So how does it actually work?
The process is straightforward and physician-led:
- Client consults their doctor
- Doctor arranges medical records and sample review
- OmixMe performs analysis
- Doctor receives the molecular report
- Doctor discusses next steps and treatment options with the client
Precision Cancer Mapping: From Broad Protocols to Targeted Possibilities.
In ideal circumstances, the client's physician will receive the completed molecular analysis within approximately 14–30 days after the tumour sample has been received and confirmed for processing.
What you can expect.
Clear, actionable deliverables for your care team, prepared within weeks.
Molecular report
Detailed, clinician-ready molecular analysis, providing the depth and evidence your oncologist needs to evaluate treatment options and make informed decisions from day one.
Targeted therapy options
We provide your oncologist with precise analysis of your tumour, which will help him set up the best possible therapy for a specific tumour in a particular patient.
Whole genome analysis
Sequenced from your tumour. DNA, RNA expression and ctDNA in one panel.
From sample to report
From sample arrival to your full report in 2 weeks to 1 month — a timeline designed to support timely decisions.
Why it matters
20–40%
Standard chemotherapy
Objective response rate in the same molecularly defined disease.
50–70%
Matched targeted therapy
Across well-validated targets like EGFR, ALK, and BRAF.
Sources: JCO Precision Oncology (2021) · Therapeutic Advances in Medical Oncology (2022).
One coordinated workflow
Sample collection, sequencing, AI interpretation, written report, expert consultation, and direct dialogue with your oncologist. Whether your tumour sample is 30 mg, 500 mg, or just a 10 mL blood draw — the process is the same.
Get transparent pricing
Once we have consulted with your oncologist to understand your specific clinical needs, we will generate a customized quote based on their input. We will then send you the price no commitment required and no hidden costs. The whole package, nothing separately billed later.
Connect us with your doctorOmixMe in one paragraph
A Simple, Stress-Free Process: From Testing to Your Targeted Treatment Plan.
We handle the logistics, the lab work, the interpretation, and the conversation with your oncologist. You and your family stay focused on what matters — your treatment and recovery.
- Records received
- Sample confirmed
- Analysis completed
- Report reviewed
- Report delivered to physician
What sets OmixMe apart from standard genetic testing.
While standard labs may focus on variant reporting, we aim to provide actionable insights your care team can use.
OmixMe helps clients gain:
- A deeper molecular understanding of their disease
- More informed discussions about treatment options
This approach helps clarify the biological nature of the disease and supports more personalized care decisions.
Not sure yet? Simply connect us with your oncologist, and our experts will send them all the necessary information.
Connect us with your doctorThe Experts Behind Your Precision Care: Why Clients and Doctors Trust OmixMe.
OmixMe is powered by Sameta Biomedical, a world-class team of bioinformaticians, AI engineers, and molecular medicine experts with decades of experience in biotech and clinical research. To ensure the highest clinical accuracy, every personalized analysis is verified by an active oncology researcher, bridging the gap between advanced data science and life-saving cancer treatment.
Verified researcher
Mgr. Miroslav Chovanec, PhD
Director of the Cancer Research Institute at the Biomedical Research Center of the Slovak Academy of Sciences, public research institution.
Contact us
contact@omixme.comEvery OmixMe report is reviewed and validated by an active oncology researcher before it reaches you.
Understanding who may benefit most.
We want to make sure OmixMe is the right fit for your situation. Please review both columns.
OmixMe is for you if…
- You or a loved one has been diagnosed with advanced or metastatic cancer (lung, breast, colorectal, pancreatic, melanoma, sarcoma, rare tumours).
- First- or second-line standard therapy is no longer effective — or your oncologist has flagged a high risk of recurrence.
- You want to know whether targeted therapy or a clinical trial exists for your specific mutation, anywhere in the world.
- You're an oncologist or institution managing complex cases and need molecular-level decision support.
OmixMe is NOT for you if…
- You're looking for a hereditary risk test (BRCA screening, family planning) — that's a different service.
- You are looking for guaranteed outcomes. OmixMe does not promise cures — we provide a detailed molecular profile of your tumour to support clinical decision-making.
- You're not ready to share your medical records or coordinate with your treating doctor — OmixMe is designed to work as part of an active care team.
Starting the conversation with your doctor.
"I've heard about personalized medicine and biomarker testing by OmixMe. I'd like to analyze my tumor sample to see if there's a therapy targeting my specific molecular typos."
"Could we explore whether personalized analytics and molecular data might help inform my cancer treatment options?"
And if you'd rather we coordinate with your oncologist directly — that's exactly what we do.
Frequently asked questions.
If yours isn't here, ask us via email below. We answer every email in person.
Your tumour has a code.
Let's help your doctor read it.
Within days, your oncologist can receive a molecular report tailored to your tumour's biology — additional information to inform treatment discussions alongside standard care.
Connect us with your doctorWe coordinate with your treating oncologist directly. No commitment required.
Get in touch.
Email us and we'll reach out to your treating oncologist with everything they need to evaluate whether OmixMe is the right next step for your care.
Rapid Reporting
An accelerated workflow so your doctor receives the report quickly.
Confidential & Secure
Your medical data remains private and is never shared without your explicit consent.
Transparent, Fixed Pricing
A comprehensive quote with no commitment and no hidden costs.
Doctor-first
Every finding is reviewed with — and delivered to — your treating physician, who remains your primary medical contact.